An EBV-Positive Lymphoproliferative Disorder after Therapy with Alemtuzumab [6] (multiple letters)

Irene M. Ghobrial, Larry A. Otteman, William L. White, David A. Rizzieri, Steve Weitman, Dana M. Vaughn

Research output: Contribution to journalLetter

26 Scopus citations
Original languageEnglish (US)
Pages (from-to)2570-2572
Number of pages3
JournalNew England Journal of Medicine
Volume349
Issue number26
DOIs
StatePublished - Dec 25 2003
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ghobrial, I. M., Otteman, L. A., White, W. L., Rizzieri, D. A., Weitman, S., & Vaughn, D. M. (2003). An EBV-Positive Lymphoproliferative Disorder after Therapy with Alemtuzumab [6] (multiple letters). New England Journal of Medicine, 349(26), 2570-2572. https://doi.org/10.1056/NEJM200312253492622